Science in the Time of COVID-19: Drug Repurposing
Between preventative vaccines and palliative treatment for the sickest COVID-19 patients lies the realm of existing drugs that could be repurposed for antiviral prophylaxis.
Between preventative vaccines and palliative treatment for the sickest COVID-19 patients lies the realm of existing drugs that could be repurposed for antiviral prophylaxis.
During this webinar, Dr. Suzanne Riches highlights a variety of approaches for conducting virology assays in a high-throughput format.
Available on demand. In this informational webinar, Dr. Dmitry Kuksin, Nexcelom Senior Scientist, examines specific virology related assays such as plaque and foci formation, as well as antibody neutralization.
Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.
Nexcelom's China team works with scientists in State Key Laboratory of Respiratory Diseases in China, for the screening of antiviral agents against SARS-CoV-2 virus, the cause of COVID-19 (Corona Virus).
Available on demand. During this webinar, Dr. Thomas will share his research in cancer biology related to DNA damage in the onset of solid tumors.
In this webinar, we highlight a variety of assays to support the development of cell therapies for solid tumors.
Improved fluorescent plaque assay method using fluorescently-labeled antibodies and the use of the Celigo image cytometer.
Improve Seahorse XF results using direct cell counting. An important step in performing SeahorseTM XF cell metabolism analysis is normalization of the resultant data.
During this webinar we will highlight a variety of assays to study the tumor microenvironment